Barclays Issues Positive Forecast for Aveanna Healthcare (NASDAQ:AVAH) Stock Price

Aveanna Healthcare (NASDAQ:AVAH) had its price objective upped by research analysts at Barclays from $9.50 to $15.00 in a research report issued on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Barclays‘s price target indicates a potential upside of 12.02% from the stock’s current price.

Several other analysts also recently weighed in on the company. Raymond James Financial boosted their target price on Aveanna Healthcare from $13.00 to $15.00 and gave the company a “strong-buy” rating in a report on Friday, August 14th. Royal Bank Of Canada raised their price target on Aveanna Healthcare from $10.00 to $16.00 and gave the stock an “outperform” rating in a research note on Monday. Stephens upgraded Aveanna Healthcare from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $10.00 to $11.00 in a research note on Friday, May 15th. Wall Street Zen downgraded Aveanna Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 15th. Finally, Truist Financial raised their target price on shares of Aveanna Healthcare from $11.00 to $15.00 and gave the stock a “hold” rating in a research report on Monday. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and five have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $13.50.

Aveanna Healthcare Stock Down 3.1%

Shares of NASDAQ AVAH traded down $0.43 during mid-day trading on Friday, reaching $13.39. The company had a trading volume of 306,795 shares, compared to its average volume of 1,816,258. The firm has a 50 day simple moving average of $10.07 and a two-hundred day simple moving average of $8.08. Aveanna Healthcare has a 52-week low of $5.93 and a 52-week high of $14.00. The company has a current ratio of 1.16, a quick ratio of 1.16 and a debt-to-equity ratio of 4.47. The stock has a market cap of $2.92 billion, a P/E ratio of 10.89, a PEG ratio of 0.86 and a beta of 1.90.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings results on Thursday, August 13th. The company reported $0.22 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.05. Aveanna Healthcare had a net margin of 10.56% and a return on equity of 80.70%. The firm had revenue of $670.48 million during the quarter, compared to analysts’ expectations of $638.61 million. Sell-side analysts predict that Aveanna Healthcare will post 0.75 earnings per share for the current year.

Insider Buying and Selling

In other Aveanna Healthcare news, major shareholder Robert M. Williams, Jr. sold 14,500,002 shares of the company’s stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Paul R. Vigano sold 14,500,002 shares of the firm’s stock in a transaction on Thursday, August 20th. The stock was sold at an average price of $11.50, for a total transaction of $166,750,023.00. The SEC filing for this sale provides additional information. Insiders have sold a total of 79,746,745 shares of company stock valued at $773,117,091 over the last quarter. 5.30% of the stock is currently owned by insiders.

Institutional Trading of Aveanna Healthcare

A number of institutional investors have recently bought and sold shares of AVAH. Caitong International Asset Management Co. Ltd increased its stake in shares of Aveanna Healthcare by 252.4% during the 4th quarter. Caitong International Asset Management Co. Ltd now owns 3,351 shares of the company’s stock worth $27,000 after purchasing an additional 2,400 shares in the last quarter. Quantbot Technologies LP acquired a new position in Aveanna Healthcare in the second quarter valued at $43,000. Summit Securities Group LLC purchased a new position in Aveanna Healthcare during the first quarter worth about $53,000. Oxford Asset Management LLP purchased a new position in shares of Aveanna Healthcare during the 2nd quarter worth about $64,000. Finally, C M Bidwell & Associates Ltd. acquired a new stake in shares of Aveanna Healthcare in the second quarter worth approximately $69,000. 87.96% of the stock is currently owned by hedge funds and other institutional investors.

About Aveanna Healthcare

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.